Inner Mongolia Furui Med Sci (300049) - Total Liabilities
Based on the latest financial reports, Inner Mongolia Furui Med Sci (300049) has total liabilities worth CN¥940.06 Million CNY (≈ $137.56 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Inner Mongolia Furui Med Sci's assets to evaluate the company's liquid asset resilience ratio.
Inner Mongolia Furui Med Sci - Total Liabilities Trend (2006–2025)
This chart illustrates how Inner Mongolia Furui Med Sci's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 300049 current and non-current assets.
Inner Mongolia Furui Med Sci Competitors by Total Liabilities
The table below lists competitors of Inner Mongolia Furui Med Sci ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Terravest Capital Inc
TO:TVK
|
Canada | CA$1.36 Billion |
|
Calibre Mining Corp
TO:CXB
|
Canada | CA$880.29 Million |
|
SSI Securities Corp
VN:SSI
|
Vietnam | ₫61.98 Trillion |
|
China-Singapore Suzhou Industrial Park Development Group Co Ltd
SHG:601512
|
China | CN¥15.96 Billion |
|
Global Net Lease, Inc.
NYSE:GNL
|
USA | $2.56 Billion |
|
TES Co. Ltd
KQ:095610
|
Korea | ₩128.46 Billion |
|
Wuxi Rural Commercial Bank Co Ltd
SHG:600908
|
China | CN¥267.88 Billion |
|
Expro Group Holdings NV
NYSE:XPRO
|
USA | $754.79 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Inner Mongolia Furui Med Sci's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Inner Mongolia Furui Med Sci balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Inner Mongolia Furui Med Sci's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Inner Mongolia Furui Med Sci (2006–2025)
The table below shows the annual total liabilities of Inner Mongolia Furui Med Sci from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥652.21 Million ≈ $95.44 Million |
-29.94% |
| 2024-12-31 | CN¥930.99 Million ≈ $136.23 Million |
+16.36% |
| 2023-12-31 | CN¥800.09 Million ≈ $117.08 Million |
+14.75% |
| 2022-12-31 | CN¥697.25 Million ≈ $102.03 Million |
-3.02% |
| 2021-12-31 | CN¥718.97 Million ≈ $105.21 Million |
+6.51% |
| 2020-12-31 | CN¥675.02 Million ≈ $98.78 Million |
-3.38% |
| 2019-12-31 | CN¥698.66 Million ≈ $102.24 Million |
+12.24% |
| 2018-12-31 | CN¥622.47 Million ≈ $91.09 Million |
+4.72% |
| 2017-12-31 | CN¥594.42 Million ≈ $86.98 Million |
+2.28% |
| 2016-12-31 | CN¥581.15 Million ≈ $85.04 Million |
+48.87% |
| 2015-12-31 | CN¥390.37 Million ≈ $57.12 Million |
-6.18% |
| 2014-12-31 | CN¥416.10 Million ≈ $60.89 Million |
+5.81% |
| 2013-12-31 | CN¥393.25 Million ≈ $57.54 Million |
+102.76% |
| 2012-12-31 | CN¥193.94 Million ≈ $28.38 Million |
+13.84% |
| 2011-12-31 | CN¥170.37 Million ≈ $24.93 Million |
+57.40% |
| 2010-12-31 | CN¥108.24 Million ≈ $15.84 Million |
+15.76% |
| 2009-12-31 | CN¥93.51 Million ≈ $13.68 Million |
+11.88% |
| 2008-12-31 | CN¥83.58 Million ≈ $12.23 Million |
+14.23% |
| 2007-12-31 | CN¥73.17 Million ≈ $10.71 Million |
+15.60% |
| 2006-12-31 | CN¥63.29 Million ≈ $9.26 Million |
-- |
About Inner Mongolia Furui Med Sci
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liv… Read more